| |
| Device | ReShape Integrated Dual Balloon System |
| Generic Name | IMPLANT, INTRAGASTRIC FOR MORBID OBESITY |
| Applicant | Boston Scientific Corporation 100 Boston Scientific Way Marlboro, MA 01752 |
| PMA Number | P140012 |
| Supplement Number | S011 |
| Date Received | 09/27/2017 |
| Decision Date | 10/26/2017 |
| Withdrawal Date | 07/23/2019 |
| Product Code |
LTI |
| Advisory Committee |
Gastroenterology/Urology |
| Supplement Type | 30-Day Notice |
| Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Reduce the frequency of sterility dose auditing for the ReShape Integrated Dual Balloon System and ReShape Removal Catheter. |